Argomenti e Notizie
sull'Osteoporosi
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Bologna
Anno 20°
Num. 126
Recens. 2429
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
 ?  
Nuova bibliografia selezionata fino al mese di febbraio 2015 (recensioni 31) Ordina per Autore - Titolo - Rivista
Langdahl BL, Teglbjaerg CS, Ho PR, Chapurlat R, Czerwinski E, Kendler DL, Reginster JY, Kivitz A, Lewiecki EM, Miller PD, Bolognese MA, McClung MR, Bone HG, Ljunggren Ö, Abrahamsen B, Gruntmanis U, Yang YC, Wagman RB, Mirza F, Siddhanti S, Orwoll E.
A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial.
J Clin Endocrinol Metab. 2015 Jan 21:jc20144079.

Conversano F, Franchini R, Greco A, Soloperto G, Chiriacò F, Casciaro E, Aventaggiato M, Renna MD, Pisani P, Di Paola M, Grimaldi A, Quarta L, Quarta E, Muratore M, Laugier P, Casciaro S.
A novel ultrasound methodology for estimating spine mineral density.
Ultrasound Med Biol. 2015 Jan;41(1):281-300. d

Piscitelli P, Auriemma R, Neglia C, Migliore A.
Alendronate: new formulations of an old and effective drug to improve adherence avoiding upper gastrointestinal side effects.
Eur Rev Med Pharmacol Sci. 2014 Dec;18(24):3788-96.

Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A.
Analysis of daily teriparatide treatment for osteoporosis in men.
Osteoporos Int. 2015 Jan 8.

Wang Y, LaMonte MJ, Hovey KM, Mai X, Tezal M, Millen AE, Ochs-Balcom HM, Genco RJ, Barnabei VM, Wactawski-Wende J.
Association of Serum 17β-Estradiol Concentration, Hormone Therapy and Alveolar Crestal Height in Postmenopausal Women.
J Periodontol. 2015 Jan 16:1-17.

Eghbali-Fatourechi G.
Bisphosphonate therapy in pediatric patients.
J Diabetes Metab Disord. 2014 Dec 17;13(1):109.

McClung MR.
Bisphosphonate therapy: how long is long enough?
Osteoporos Int.2015 Jan 22.

Rossini M, Orsolini G, Viapiana O, Adami S, Gatti D.
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.
Endocrine. 2015 Feb 4.

Aguado E, Pascaretti-Grizon F, Goyenvalle E, Audran M, Chappard D.
Bone mass and bone quality are altered by hypoactivity in the chicken.
PLoS One. 2015 Jan 30

Eisenberg DF, Placzek H, Gu T, Krishna A, Tulsi BB.
Cost and consequences of noncompliance to oral bisphosphonate treatment.
J Manag Care Spec Pharm. 2015 Jan;21(1):56-65.

Genazzani AR, Komm BS, Pickar JH.
Emerging hormonal treatments for menopausal symptoms.
Expert Opin Emerg Drugs. 2015 Jan 5:1-16.

Hakestad KA, Torstveit MK, Nordsletten L, Axelsson ÅC, Risberg MA.
Exercises Including Weight Vests and a Patient Education Program for Women With Osteopenia: A Feasibility Study of the OsteoACTIVE Rehabilitation Program.
J Orthop Sports Phys Ther. 2015 Feb;45(2):97-105.

Overman RA, Gourlay ML, Deal CL, Farley JF, Brookhart MA, Layton JB.
Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.
Osteoporos Int. 2015 Jan 20.

Bianchi ML, Duca P, Vai S, Guglielmi G, Viti R, Battista C, Scillitani A, Muscarella S, Luisetto G, Camozzi V, Nuti R, Caffarelli C, Gonnelli S, Albanese C, De Tullio V, Isaia G, D'Amelio P, Broggi F, Croci M.
Improving adherence to and persistence with oral therapy of osteoporosis.
Osteoporos Int. 2015 Jan 27.

Andreopoulou P, Bockman RS.
Management of postmenopausal osteoporosis.
Annu Rev Med. 2015 Jan 14;66:329-42.

Hansen KA.
Osteoporosis: don't forget men.
S D Med. 2014 Dec;67(12):491.

Herrera A, Mateo J, Gil-Albarova J, Lobo-Escolar A, Artigas JM, López-Prats F, Mesa M, Ibarz E, Gracia L.
Prevalence of osteoporotic vertebral fracture in Spanish women over age 45.
Maturitas. 2014 Dec 18.

Daugschies M, Brixen K, Hermann P, Rohde K, Glüer CC, Barkmann R.
Quantitative Ultrasound Measurements at the Heel: Improvement of Short- and Mid-Term Speed of Sound Precision.
Ultrasound Med Biol. 2015 Jan 22. pii:

Wada Y, Hisamatsu T, Naganuma M, Matsuoka K, Okamoto S, Inoue N, Yajima T, Kouyama K, Iwao Y, Ogata H, Hibi T, Abe T, Kanai T.
Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study.
Clin Nutr. 2015 Jan 13

Ikeda T, Kuraguchi J, Kogashiwa Y, Yokoi H, Satomi T, Kohno N.
Successful treatment of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) patients with sitafloxacin: New strategies for the treatment of BRONJ.
Bone. 2014 Dec 27;73C:217-222.

Xinluan W, Yuxiao L, HueiLengHelena NG, Zhijun Y, Ling Q.
Systemic Drug Delivery Systems for Bone Tissue Regeneration- A Mini Review.
Curr Pharm Des. 2015 Jan 15.

Bonafede MM, Shi N, Bower AG, Barron RL, Grauer A, Chandler DB.
Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
Osteoporos Int. 2015 Jan 8.

Tuchendler D, Bolanowski M.
The influence of thyroid dysfunction on bone metabolism.
Thyroid Res. 2014 Dec 20;7(1):12.

El Miedany Y.
Treat to Target for Osteoporosis: Another step forward.
Curr Rheumatol Rev. 2015 Jan 13.

Wittayanukorn S, Qian J, Westrick SC, Billor N, Johnson B, Hansen RA.
Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments.
Res Social Adm Pharm. 2014 Dec 18.

Burden AM, Tadrous M, Calzavara A, Cadarette SM.
Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access.
Osteoporos Int. 2015 Jan 21.

Holt A, Khan MA, Gujja S, Govindarajan R.
Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy.
Cancer Manag Res. 2014 Dec 24;7:13-8.

Punda M, Grazio S.
[Bone densitometry--the gold standard for diagnosis of osteoporosis].
Reumatizam. 2014;61(2):70-4.

Carranza-Lira S, Lanuza-López MC, Sandoval-Barragán MP.
[Comparison fracture risk calculated by FRAX tool].
Ginecol Obstet Mex. 2014 Sep;82(9):591-4.

Pfeifer M, Hinz Ch, Lazarescu AD, Minne HW.
[Evaluation and socio-economic relevance of an integrated osteoporosis health care network].
Versicherungsmedizin. 2014 Dec 1;66(4):198-201.

Veiga Silva AC, Da Rosa MI, Fernandes B, Lumertz S, Diniz RM, Dos Reis Damiani ME.
[Factors associated with osteopenia and osteoporosis in women undergoing bone mineral density test.].
Rev Bras Reumatol. 2014 Oct 24.

(Vers. 2.1)  Modificato il 7-2-2015
http://www.tarozzi.net   
questo sito aderisce ai principi HONCODE    disclaimer